Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections

被引:82
作者
Blairon, L
Wittebole, X
Laterre, PF
机构
[1] St Luc Univ Hosp, Dept Biol Clin, Brussels, Belgium
[2] St Luc Univ Hosp, Dept Intens Care & Emergency Med, Brussels, Belgium
关键词
D O I
10.1086/346046
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lipopolysaccharide-binding protein (LBP) is increased in patients with severe gram-negative infections, but LBP serum levels have not been reported for in patients with gram-positive and fungal infections. LBP serum levels were determined in patients with severe sepsis secondary to gram-positive or fungal infections and were compared with LBP serum levels obtained from patients with gram-negative mixed infections and from healthy volunteers. Thirty-seven episodes of severe sepsis were analyzed among 24 patients. LBP serum levels were significantly increased in patients with severe sepsis (46.4 +/- 28.3 mug/mL), compared with that of healthy volunteers (5.7 +/- 1.9 mug/mL; P < .0001). On the other hand, LBP serum levels obtained from patients with gram-negative infections (40.80 +/- 34.79 μg/mL) did not differ from those obtained from patients with gram-positive (35.55 +/- 23.95 μg/mL) or fungal (39.90 +/- 22.19 μg/mL) infections. These data suggest that LBP is an aspecific marker of sepsis, and the response was not clearly correlated with severity. Furthermore, in patients with multiple episodes of sepsis, LBP response seems to be of lesser magnitude after each subsequent episode of severe sepsis.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 23 条
[1]  
BABSON AL, 1991, CLIN CHEM, V37, P1521
[2]   Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis [J].
Berner, R ;
Fürll, B ;
Stelter, F ;
Dröse, J ;
Müller, HP ;
Schütt, C .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (02) :440-445
[3]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[4]  
BOUMA M, 1997, CHEST, V111, P557
[5]   LIPOPOLYSACCHARIDE TOXICITY-REGULATING PROTEINS IN BACTEREMIA [J].
FROON, AHM ;
DENTENER, MA ;
GREVE, JWM ;
RAMSAY, G ;
BUURMAN, WA .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (05) :1250-1257
[6]   LIPOPOLYSACCHARIDE-BINDING PROTEIN AS A MAJOR PLASMA-PROTEIN RESPONSIBLE FOR ENDOTOXEMIC SHOCK [J].
GALLAY, P ;
HEUMANN, D ;
LEROY, D ;
BARRAS, C ;
GLAUSER, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9935-9938
[7]  
GELLER DA, 1993, ARCH SURG-CHICAGO, V128, P22
[8]   SEPTIC SHOCK - PATHOGENESIS [J].
GLAUSER, MP ;
ZANETTI, G ;
BAUMGARTNER, JD ;
COHEN, J .
LANCET, 1991, 338 (8769) :732-736
[9]   Strong association of interleukin-6 and lipopolysaccharide-binding protein with severity of adverse reactions after diethylcarbamazine treatment of microfilaremic patients [J].
Haarbrink, M ;
Abadi, GK ;
Buurman, WA ;
Dentener, MA ;
Terhell, AJ ;
Yazdanbakhsh, M .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (02) :564-569
[10]   Isolation, partial characterization, and concentration in experimental sepsis of baboon lipopolysaccharide-binding protein [J].
Haudek, SB ;
Natmessnig, BE ;
Redl, H ;
Schlag, G ;
Hatlen, LE ;
Tobias, PS .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2000, 136 (05) :363-370